Virtual Reality for Preoperative Anxiety in Interventional Cardiology (No PANIC)

December 18, 2025 updated by: University Hospital, Grenoble
Improving the management of perioperative anxiety is important. Anxiety can have an impact on the intervention and can increase postoperative complications as well as emotional and behavioral incidents that then have an impact on adherence to care. These findings are also true in interventional cardiology. That is why, for several months, the Grenoble University hospital paramedical team, in collaboration with the medical profession, improved by using several techniques (educational sheet, therapeutic communication). Following a survey of the patients of Grenoble university hospital, a gray area persists in their care. The room where the patient attends his examination. The investigators would then use the new technology that makes virtual reality in the transfer room to evaluate its benefit in a random study on preoperative anxiety in interventional cardiology.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

156

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Grenoble, France, 38043
        • Grenoble University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Major male or female patient
  • Coronarography procedure programmed for exploration of coronary artery disease following a positive ischemia test, realized in ambulatory
  • Patient who has given written consent to participate in the study

Exclusion Criteria:

  • Arrhythmia patient and / or patient with a pacemaker
  • Hemodynamic instability
  • Patient who has already had coronarography
  • Prior revascularization by coronary bypass
  • End-stage renal disease (Creatinine clearance <30 ml / min),
  • Allergy to iodine contrast agent
  • Blind or visually impaired patient (high degree)
  • Deaf or hard of hearing patient
  • Patient with claustrophobia or unable to wear a mask over the eyes
  • Patient whose physical or psychological state could compromise obtaining informed consent and compliance with protocol requirements
  • Patient under administrative or judicial supervision
  • Foreign patient who does not understand French
  • Major patient protected by law (article L1121-8 and L1121-5)
  • Pregnant or lactating patient
  • Patient not affiliated with social security

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: CONTROL GROUP
No virtual reality
Experimental: INTERVENTION GROUP
Patient equipped with Virtual reality in transfer room.
Patient equipped with virtual reality in transfer room

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effectiveness of virutal reality on the management of preoperative anxiety measured by heart rate variability in interventional cardiology room in patient awaiting coronarography
Time Frame: Time 1 : 60 minutes
Heart rate variability during 20 minutes by a heart rate monitor in transfer room
Time 1 : 60 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of anxiety level in patient awaiting coronarography
Time Frame: TIme 1 : 60 minutes, Time 2 : 120 minutes
The Analogical Self-Assessment Scale for Preoperative Anxiety (0 - no anxiety to 10 - uncontrollable anxiety)
TIme 1 : 60 minutes, Time 2 : 120 minutes
Patient satisfaction on the global care in the coronary angiography room
Time Frame: Time 3 : 180 minutes
Patient satisfaction questionnaire
Time 3 : 180 minutes
Impact of virtual reality on coronarography intervention duration
Time Frame: Time 2 : 120 minutes
Intervention duration (in minutes)
Time 2 : 120 minutes
Impact of virtual reality on coronarography irradiation dose
Time Frame: Time 2 : 120 minutes
Irradiation dose (in Gy.cm²)
Time 2 : 120 minutes
Impact of virtual reality on coronarography scopy time
Time Frame: Time 2 : 120 minutes
scopy time (in minutes)
Time 2 : 120 minutes
Impact of virtual reality on administration of analgesic and anxiolytic drug peri and per coronarography procedure
Time Frame: Time 2 : 120 minutes
administration of analgesic and anxiolytic drug peri and perprocedure (drug name and dose)
Time 2 : 120 minutes
Impact of virtual reality on rate and success of coronarography procedure
Time Frame: Time 2 : 120 minutes
number and success of PCI
Time 2 : 120 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2020

Primary Completion (Actual)

July 12, 2021

Study Completion (Actual)

July 12, 2021

Study Registration Dates

First Submitted

December 30, 2019

First Submitted That Met QC Criteria

January 22, 2020

First Posted (Actual)

January 27, 2020

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 18, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 38RC19.116

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on VIRTUAL REALITY

Subscribe